Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Video Conferencing Instruments for Virtual Gatherings - 2Vote In favor of Your #1 Electric Vehicles
- 3Israel says Iran's military industry will be destroyed 'within days'
- 4Scientists sent a menstrual cup to space. This is how it went
- 57 Peculiar Ways Of starting Your Imagination: Motivation Has Never Been This Good times
- Vote In favor of Your Favored Kind Of Tea
- 'Peaky Blinders: The Immortal Man' teaser trailer reveals Cillian Murphy's Tommy Shelby back in action
- Inside Plan with Houseplants: An Aide
- Former elite Australian soldier charged with Afghan war crimes
- Find Your Internal Culinary expert: Cooking Strategies and Recipes
- The most effective method to Guarantee Scholastic Honesty in Web-based Degrees
- Famous Kitchen Finishing Styles For 2024
- Home Wellness Basics: Building Your Home Exercise center
- Nestlé recalls infant formula in 49 countries. See list.
